GSTP1 | Glutathione S-transferase pi 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
HSF1 | Heat shock transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
HSP90B1 | Heat shock protein 90kDa beta (Grp94), member 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HSPA4 | Heat shock 70kDa protein 4 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HSPB1 | Heat shock 27kDa protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
HSPD1 | Heat shock 60kDa protein 1 (chaperonin) | Cancer-related genes Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
HSPH1 | Heat shock 105kDa/110kDa protein 1 | Cancer-related genes
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA6 | Integrin, alpha 6 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAV | Integrin, alpha V | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGB4 | Integrin, beta 4 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGB5 | Integrin, beta 5 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
JTB | Jumping translocation breakpoint | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
JUP | Junction plakoglobin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
KIF2A | Kinesin heavy chain member 2A | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
KIF2C | Kinesin family member 2C | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
KRT17 | Keratin 17 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
KRT18 | Keratin 18 | Cancer-related genes Disease related genes
| | | | | Mixed |
KRT19 | Keratin 19 | Cancer-related genes Plasma proteins
| | | | | Mixed |
KRT8 | Keratin 8 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
LAMB1 | Laminin, beta 1 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
LAMC1 | Laminin, gamma 1 (formerly LAMB2) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
LGALS3 | Lectin, galactoside-binding, soluble, 3 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LGALS3BP | Lectin, galactoside-binding, soluble, 3 binding protein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
LIMK1 | LIM domain kinase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LMNA | Lamin A/C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAGEC1 | Melanoma antigen family C, 1 | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
MAGI1 | Membrane associated guanylate kinase, WW and PDZ domain containing 1 | Cancer-related genes Plasma proteins
| | | | | Mixed |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MCM2 | Minichromosome maintenance complex component 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM3 | Minichromosome maintenance complex component 3 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM5 | Minichromosome maintenance complex component 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM7 | Minichromosome maintenance complex component 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MGMT | O-6-methylguanine-DNA methyltransferase | Cancer-related genes Enzymes
| | | | | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |